Old drugs, new uses: Drug repurposing in hematological malignancies.

Seminars in Cancer Biology
Vijay P KaleManoj K Pandey

Abstract

Discovery and development of novel anti-cancer drugs are expensive and time consuming. Systems biology approaches have revealed that a drug being developed for a non-cancer indication can hit other targets as well, which play critical roles in cancer progression. Since drugs for non-cancer indications would have already gone through the preclinical and partial or full clinical development, repurposing such drugs for hematological malignancies would cost much less, and drastically reduce the development time, which is evident in case of thalidomide. Here, we have reviewed some of the drugs for their potential to repurpose for treating the hematological malignancies. We have also enlisted resources that can be helpful in drug repurposing.

References

Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·R J D'AmatoJ Folkman
Nov 24, 1999·The New England Journal of Medicine·S SinghalB Barlogie
Jun 30, 2000·The New England Journal of Medicine·G SteinbachG Kelloff
Sep 1, 2000·Science·S L Teitelbaum
Jan 3, 2001·Kidney International·R N SaundersM L Nicholson
Apr 12, 2001·The Journal of Biological Chemistry·J A KeiferA S Baldwin
Jul 5, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·S Singhal, J Mehta
Mar 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sekhar MajumdarBharat B Aggarwal
Sep 10, 2003·Experimental Hematology·Daphne Chapman-ShimshoniMichael Lishner
Nov 20, 2004·Blood·Christian RécherBernard Payrastre
Mar 30, 2005·American Journal of Hematology·Thomas E CoyleJonathan Wright
Aug 30, 2005·Molecular & Cellular Proteomics : MCP·Mathias UhlénFredrik Pontén
Oct 26, 2005·American Journal of Hematology·Mustafa CetinAli Unal
Feb 25, 2006·Cell Death and Differentiation·T BraunG Kroemer
Dec 23, 2006·Nature Reviews. Cancer·Justin Lamb
Jan 16, 2007·British Journal of Haematology·Roger G OwenAndy C Rawstron
May 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kwang-Il GohAlbert-László Barabási
Aug 10, 2007·Nature·Curtis R Chong, David J Sullivan
Jan 5, 2008·European Journal of Clinical Investigation·C SillaberP Valent
Apr 17, 2008·Pharmacoepidemiology and Drug Safety·Yu-Xiao YangJames D Lewis
Jun 4, 2008·International Journal of Cancer. Journal International Du Cancer·Soo-Jeong ChoIn Sung Song
Aug 12, 2008·Current Pharmaceutical Design·M P BernardR P Phipps
Jan 2, 2009·The New England Journal of Medicine·Robert S WeinsteinStavros C Manolagas
Aug 7, 2009·PloS One·Guanghui Hu, Pankaj Agarwal
Oct 9, 2009·Journal of Cell Science·Mathieu Laplante, David M Sabatini
Feb 20, 2010·Nature Reviews. Drug Discovery·Steven M PaulAaron L Schacht
Mar 20, 2010·Diabetes Care·Michael BodmerChristoph R Meier
May 1, 2010·Blood·Bernard Klein
May 7, 2010·Cell Metabolism·Adem KalenderGeorge Thomas
Oct 5, 2010·Oncotarget·Yulia N Demchenko, W Michael Kuehl
Nov 12, 2010·Nucleic Acids Research·David CroftLincoln Stein
Dec 9, 2010·Nature Biotechnology·Mathias UhlenFredrik Ponten
Feb 25, 2011·Cancer Letters·Verena Jendrossek
May 6, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Guilherme Z RochaJosé B C Carvalheira
Aug 10, 2011·Current Opinion in Supportive and Palliative Care·James R Berenson
Nov 15, 2011·Nucleic Acids Research·Michael KuhnPeer Bork
Dec 29, 2011·Oncotarget·Sonia Del BarcoJavier A Menendez

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Trends in Cancer
Ciska VerbaanderdPan Pantziarka
Current Medicinal Chemistry
Levon M Khachigian
Journal of Cancer Science & Therapy
Carlos M Telleria
© 2021 Meta ULC. All rights reserved